Titan Pharmaceuticals Inc.
TTNP | NASDAQ
$2.34
-$0.30 (-11.36%)
At close: Dec 16, 2025, 1:46 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Net Income | -2.49M | -4.71M | -5.57M | -10.21M | -8.78M | -18.24M |
Depreciation & Amortization | n/a | 5K | 112K | 196K | 221K | 292K |
Stock-Based Compensation | n/a | n/a | 1.01M | 997K | 1.51M | 7K |
Other Working Capital | -799K | -78K | -430K | 866K | 295K | -556K |
Other Non-Cash Items | n/a | -2K | -1.73M | 452K | -5K | 482K |
Deferred Income Tax | n/a | n/a | n/a | n/a | -661K | -760K |
Change in Working Capital | -924K | 823K | -916K | 378K | -219K | 1.02M |
Operating Cash Flow | -3.41M | -3.88M | -7.09M | -8.18M | -7.9M | -17.2M |
Capital Expenditures | -5K | n/a | -2K | n/a | -23K | -540K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -3.16M | n/a | 734K | n/a | -23K | -540K |
Investing Cash Flow | -3.16M | n/a | 732K | n/a | -23K | -540K |
Debt Repayment | n/a | n/a | 500K | n/a | n/a | -946K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.47M | -62K | n/a | 4K | n/a | 7.24M |
Financial Cash Flow | 4.07M | -62K | 10M | 4.98M | 8.84M | 17.93M |
Net Cash Flow | -2.5M | -3.94M | 3.64M | -3.2M | 919K | 190K |
Free Cash Flow | -3.41M | -3.88M | -7.09M | -8.18M | -7.92M | -17.74M |
Adj. Free Cash Flow | -3.41M | -3.88M | -8.11M | -9.18M | -9.43M | -17.75M |
Maintenance CapEx | -5K | n/a | -2K | n/a | -23K | -311.5K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | -228.5K |
Owner Earnings | -3.41M | -3.88M | -7.09M | -8.18M | -7.92M | -17.51M |
Add to Watchlist
Select watchlists to add or remove TTNP